L19.4 Kilder

Kvalmestillende legemidler

Munoz M, Convenas R, Esteban F et al. 2015 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J. Biosci. 2015; 40: 441–463

Jin Y, Sun W, Gu D et al. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis. Eur J Cancer Care (Engl) 2013;22:41-50.

Popovic M, Warr DG, Deangelis C, et al. Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer 2014;22:1685-97.

EMA Summary of opinion Ivemend (fosaprepitant) 22 March 2018